Stage I and II nonsmall cell lung cancer treatment options.

Breathe (Sheff) · 2024 · PMC11348908 · PMID 39193460

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Median OS from the 4-year survival update also showed a trend towards improvement but did not reach the significance boundary at interim analysis.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.